Literature DB >> 33401480

Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure.

Marina Yu Kopaeva1, Anton B Cherepov1, Mikhail V Nesterenko2, Irina Yu Zarayskaya1.   

Abstract

We studied the effect of human lactoferrin (hLf) on degenerative changes in the nigrostriatal system and associated behavioral deficits in the animal model of Parkinson disease. Nigrostriatal dopaminergic injury was induced by single administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 40 mg/kg) to five-month-old C57Bl/6 mice. Behavioral disturbances were assessed in the open field and rotarod tests and by the stride length analysis. Structural deficits were assessed by the counts of tyrosine hydroxylase (TH)-immunoreactive neurons in the substantia nigra and optical density (OD) of TH-immunolabeled fibers in the striatum. Acute MPTP treatment induced long-term behavioral deficit and degenerative changes in the nigrostriatal system. Pretreatment with hLf prevented body weight loss and promoted recovery of motor functions and exploratory behavior. Importantly, OD of TH-positive fibers in the striatum of mice treated with hLf almost returned to normal, and the number of TH-positive cells in the substantia nigra significantly increased on day 28. These results indicate that hLf produces a neuroprotective effect and probably stimulates neuroregeneration under conditions of MPTP toxicity in our model. A relationship between behavioral deficits and nigrostriatal system disturbances at delayed terms after MPTP administration was found.

Entities:  

Keywords:  MPTP; Parkinson’s disease; dopaminergic neurons; human lactoferrin; striatum; substantia nigra

Year:  2021        PMID: 33401480      PMCID: PMC7823682          DOI: 10.3390/biology10010024

Source DB:  PubMed          Journal:  Biology (Basel)        ISSN: 2079-7737


  58 in total

1.  Trans-endothelial and trans-epithelial transfer of lactoferrin into the brain through BBB and BCSFB in adult rats.

Authors:  Nao Kamemori; Takashi Takeuchi; Akihiko Sugiyama; Mariko Miyabayashi; Hiroshi Kitagawa; Hirohiko Shimizu; Kunio Ando; Etsumori Harada
Journal:  J Vet Med Sci       Date:  2008-03       Impact factor: 1.267

2.  Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues.

Authors:  G J Ziere; M C van Dijk; M K Bijsterbosch; T J van Berkel
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

Review 3.  Parkinson's disease.

Authors:  Lorraine V Kalia; Anthony E Lang
Journal:  Lancet       Date:  2015-04-19       Impact factor: 79.321

4.  β-Estradiol-3-benzoate confers neuroprotection in Parkinson MPP+ rat model through inhibition of lipid peroxidation.

Authors:  Yoshajandith Aguirre-Vidal; Antonio Monroy-Noyola; Laura Anaya-Ramos; Marcela Arteaga-Silva; Marisela Mendez-Armenta; Pedro Ostoa-Saloma; Mariana Díaz-Zaragoza; Jorge Morales-Montor; Camilo Ríos; Sergio Montes
Journal:  Steroids       Date:  2017-08-04       Impact factor: 2.668

5.  The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis.

Authors:  Erwann Rousseau; Patrick P Michel; Etienne C Hirsch
Journal:  Mol Pharmacol       Date:  2013-09-27       Impact factor: 4.436

6.  Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.

Authors:  E Sundström; A Fredriksson; T Archer
Journal:  Brain Res       Date:  1990-10-01       Impact factor: 3.252

7.  Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

Authors:  Sheila M Fleming; Jonathan Salcedo; Pierre-Olivier Fernagut; Edward Rockenstein; Eliezer Masliah; Michael S Levine; Marie-Françoise Chesselet
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

Review 8.  Redox active metals in neurodegenerative diseases.

Authors:  Karla Acevedo; Shashank Masaldan; Carlos M Opazo; Ashley I Bush
Journal:  J Biol Inorg Chem       Date:  2019-10-24       Impact factor: 3.358

9.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

Authors:  D T Dexter; A Carayon; F Javoy-Agid; Y Agid; F R Wells; S E Daniel; A J Lees; P Jenner; C D Marsden
Journal:  Brain       Date:  1991-08       Impact factor: 13.501

10.  PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson's disease mouse model.

Authors:  Jong Kyu Youn; Dae Won Kim; Seung Tae Kim; Sung Yeon Park; Eun Ji Yeo; Yeon Joo Choi; Hae-Ran Lee; Duk-Soo Kim; Sung-Woo Cho; Kyu Hyung Han; Jinseu Park; Won Sik Eum; Hyun Sook Hwang; Soo Young Choi
Journal:  BMB Rep       Date:  2014-10       Impact factor: 4.778

View more
  2 in total

Review 1.  Iron Metabolism in Aging and Age-Related Diseases.

Authors:  Yao Tian; Yuanliangzi Tian; Zhixiao Yuan; Yutian Zeng; Shuai Wang; Xiaolan Fan; Deying Yang; Mingyao Yang
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

2.  Beneficial effect of transient desflurane inhalation on relieving inflammation and reducing signaling induced by MPTP in mice.

Authors:  Zhiyang Yu; Guowei Qin; Zhenzhong Ge; Weiyan Li
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.